Phase II Study of Single Agent Lenvatinib

NCT03168074 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: lenvatinib

Sponsor

National University Hospital, Singapore

Collaborators

[object Object]
[object Object]